Xconomy Seattle

MolecularMD Lands $3,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7c1ec71f-dbc7-449c-befe-c95f67915358&Preview=1
Date
1/30/2009
Company Name
MolecularMD
Mailing Address
2611 SW 3rd Ave. Portland, OR 97201
Company Description
Founded in 2006, MolecularMD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art genomic assays to measure patient response and resistance to targeted cancer therapies. The company has over 30 years of combined experience in cancer research and has developed sensitive and highly reliable molecular assays for leukemias, lymphomas, and solid tumors.
Website
http://www.molecularmd.com
Transaction Type
Venture Equity
Transaction Amount
$3,000,000
Transaction Round
Undisclosed
Proceeds Purposes
This financing will be used to build MolecularMD’s corporate infrastructure and to expand the company’s assay portfolio.
M&A Terms
Venture Investor
Ballast Point Venture Partners